Related Experiment Video
Updated: Jun 22, 2026
14:53
Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
Published on: June 26, 2020
Amnion: a potent graft source for cell therapy in stroke.
Seong Jin Yu1, Maddalena Soncini, Yuji Kaneko
1Department of Neurology, Medical College of Georgia, Augusta, GA, USA.
Cell Transplantation
|June 9, 2009
Summary
Amnion-derived cells offer a promising, ethically sound source for regenerative medicine. These cells show potential for treating central nervous system disorders like stroke.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Neuroscience
Background:
- Regenerative medicine utilizes stem cells for tissue repair.
- Amnion-derived cells are a novel cell source with multipotent differentiation capabilities.
- These cells offer advantages over embryonic stem cells, including low immunogenicity and ethical considerations.
Purpose of the Study:
- To review the characterization of amnion-derived mesenchymal stem cells (MSCs).
- To highlight their therapeutic potential for central nervous system (CNS) disorders.
- To discuss their application in regenerative medicine, particularly for stroke treatment.
Main Methods:
- Review of current literature on amnion-derived MSCs.
- Characterization of their differentiation potential.
- Assessment of their immunomodulatory and anti-inflammatory properties.
Main Results:
- Amnion-derived cells can differentiate into all three germ layers.
- They possess low immunogenicity and anti-inflammatory functions.
- Evidence supports their therapeutic potential for CNS disorders, including stroke.
Conclusions:
- Amnion-derived MSCs represent a potent, ethically viable cell source for regenerative medicine.
- Their unique properties make them suitable for transplantation therapies.
- Further research is warranted to explore their full therapeutic capacity for neurological conditions.
